NIM
REGN icon

NuWave Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

NuWave Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,290
Closed -$815K – 363
2021
Q4 		$815K Buy
1,290
+72
+6% +$44.3K 0.92% 21
2021
Q3 		$737K Buy
+1,218
New +$756K 0.84% 28
2021
Q2 		– Sell
-742
Closed -$351K – 402
2021
Q1 		$351K Sell
742
-2,153
-74% -$1.05M 0.44% 80
2020
Q4 		$1.4M Buy
2,895
+2,601
+885% +$1.4M 1.83% 3
2020
Q3 		$164K Buy
294
+266
+950% +$161K 0.25% 130
2020
Q2 		$17K Sell
28
-594
-95% -$337K 0.02% 287
2020
Q1 		$304K Buy
622
+598
+2,492% +$247K 0.66% 31
2019
Q4 		$9K Sell
24
-236
-91% -$79.4K 0.01% 345
2019
Q3 		$78K Buy
260
+180
+225% +$53.3K 0.08% 215
2019
Q2 		$25K Sell
80
-1,182
-94% -$394K 0.03% 283
2019
Q1 		$519K Buy
1,262
+1,238
+5,158% +$510K 0.61% 56
2018
Q4 		$9K Buy
24
+22
+1,100% +$8.05K 0.02% 269
2018
Q3 		$1K Sell
2
-1
-33% -$381 ﹤0.01% 383
2018
Q2 		$1K Buy
+3
New +$938 ﹤0.01% 354

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NuWave Investment Management's REGN Position: Q1 2022 in Review

NuWave Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q1 2022, closing a stake of 1,290 shares — an estimated $815K sold.

NuWave Investment Management first reported a position in REGN in Q2 2018 and held it in 14 quarters. The position peaked at $1.4M in Q4 2020. 1,095 funds tracked by Wall St. Rank hold REGN as of Q1 2022.

  • NuWave Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • NuWave Investment Management sold 1,290 Regeneron Pharmaceuticals shares in Q1 2022, an estimated $815K.
  • NuWave Investment Management first reported a position in Regeneron Pharmaceuticals in Q2 2018 and held it in 14 quarters.
  • NuWave Investment Management's Regeneron Pharmaceuticals position peaked at $1.4M in Q4 2020.
  • 1,095 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2022.

Based on NuWave Investment Management's 13F filing for Q1 2022, filed 12 Apr 2022.